Bio-Techne
TECH · NASDAQ
$72.58+$0.09 (+0.12%)TodayMarket closed ·
Prev close $72.49
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 5.9% on average
Next report: , before the market opens
- Quarter
- Q1 FY27
- EPS estimate
- $0.44
- Revenue estimate
- $292.45M
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $0.5295 | $0.52 | −1.8% |
| Q1 FY26 | $0.5483 | $0.53 | −3.3% |
| Q4 FY25 | $0.5089 | $0.53 | +4.1% |
| Q3 FY25 | $0.5216 | $0.56 | +7.4% |
| Q2 FY25 | $0.3941 | $0.42 | +6.6% |
| Q1 FY25 | $0.3898 | $0.42 | +7.7% |
| Q4 FY24 | $0.504 | $0.49 | −2.8% |
| Q3 FY24 | $0.4619 | $0.48 | +3.9% |
Earnings calls
- Bio-Techne Corporation, Merck KGaA - M&A Call
- Bank of America Global Healthcare Conference 2026
- TECH - Earnings call Q3 2026
- Leerink Global Healthcare Conference 2026
- TD Cowen 46th Annual Health Care Conference
- TECH - Earnings call Q2 2026
- 44th Annual J.P. Morgan Healthcare Conference
- 53rd Annual Nasdaq Investor Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.